HHS Cancels $500M in mRNA Vaccine Contracts, Winding Down Respiratory Virus Efforts

Health Secretary Robert F. Kennedy Jr.’s determination that mRNA respiratory vaccines pose more risks than benefits, reinforced by Jay Bhattacharya’s emphasis on lost public trust, is drawing alarm over potential setbacks to U.S. pandemic readiness.